Definition
The constitutive androstane receptor (CAR), a member of the nuclear receptor subfamily 1 (NR1I3- nuclear receptor subfamily 1, group I, member 3), initially identified as a xenosensor (sensor of xenobiotics), is a functionally pleiotropic, liver-enriched transcription factor with roles in various cellular processes and diseases.
Characteristics
Human CAR, first cloned in 1994 (and called MB67 at that point of time), was originally regarded as an “orphan” nuclear receptor, with no apparent endogenous ligand. It is expressed to the highest extent in the liver and small intestine. Additionally, unlike many nuclear receptors requiring the presence of a ligand to activate and cause its translocation from the cytoplasm to the nucleus, CAR, in heterodimerization with 9-cis retinoic acid receptor (RXR), transactivates and exhibits “basal” activity even in the absence of ligand. Hence, it initially came to be known as the “constitutively active receptor.” Later,...
Abbreviations
- CITCO:
-
6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-[3,4-dichlorobenzyl)oxime
- TCPOBOP:
-
1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene
References
Cherian MT, Chai SC, Chen T (2015) Small-molecule modulators of the constitutive androstane receptor. Expert Opin Drug Metab Toxicol 11(7):1099–1114
Molnar F, Küblbeck J, Jyrkkärinne J, Prantner V, Honkakoski P (2013) An update on the constitutive androstane receptor (CAR). Drug Metabol Drug Interact 28(2):79–93
Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM (2011) Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxcicities. Toxicol Sci 120(S1):S49–S75
See Also
(2012) Nuclear receptor. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2571. doi:10.1007/978-3-642-16483-5_4157
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Glossary
- Inverse agonist
-
An agent capable of binding to the same receptor binding-site as the agonist but causing a pharmacologically opposite effect as that of the agonist in a constitutively active receptor (i.e., a receptor exhibiting a certain level of intrinsic basal activity). In other words they cause a reduction of the basal expression. Depending on the affinity of the ligand to the receptor, inverse antagonism could be complete or partial.
- Pregnane X receptor (PXR)
-
A member of the nuclear receptor subfamily 1, group I (NR1I2), along with the constitutive androstane receptor (CAR) and vitamin D receptor (VDR). PXR, similar to CAR, has also been predominantly found to be expressed in the liver. It primarily serves as a xenobiotic and steroid hormone sensor. Human PXR was initially reported as a steroid and xenobiotic receptor and hence also called SXR. Along with CAR, PXR shares several similarities in its mechanism of action, along with overlapping roles in many of the physiological and disease processes, including inflammation and cancer.
- Nuclear receptor structure
-
Nuclear receptors are modular in structure with five-six domains, N to C terminus. These include an N-terminal A/B regulatory region with transcriptional activation function (AF-1) domain, a C region with a DNA-binding domain (DBD), a hinge D region and an E region with a ligand-binding domain (LBD) containing an activation function (AF-2) at its end.
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
John, K. (2015). Constitutive Androstane Receptor. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_7229-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-27841-9_7229-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27841-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences